Have you considered that microneedle drug delivery systems could revolutionise the future of vaccine and drug administration?
Discover the future of drug delivery at our 3rd annual
Transdermal and Microneedle Drug Delivery conference, where we lead the transition beyond the needle.
Collaborate with forward-thinking experts in a high-level 2-day program, discussing case studies and real-world examples in delivery R&D, vaccine application, and diversifying capabilities.
Transdermal and Microneedle Array Patches (MAPs) are revolutionizing pharmaceutical development, offering unparalleled potency, increased community access, consistent long-term delivery, and advanced diagnostic capabilities, making this technology a frontrunner in enhancing efficacy and global access to transformative products.
Highlights include:
- Successes in clinical data and vaccine delivery
- Innovative capabilities and applications of transdermal and microneedle patches
- Manufacturing challenges and progress
- Insights and Q&A opportunities with key regulators
Why you need to attend?
- Engage and connect with senior industry opinion leaders presenting their experiences and studies in modern strategies for topical and transdermal drug delivery
- Gain insights from key industry experts on transdermal and microneedle systems as tools for therapeutic drug delivery
- Understand how to optimise design and manufacturing development of transdermal delivery technologies
- Explore and benchmark against industry advances in microneedle diagnostics through case studies and real-world examples
Featured Speakers
- Aleksandra Puton, Business Manager, Biotts
- Brian Pfister, Vice President, Emergex USA Corporation
- Clemens Gunther, Former Senior Expert Nonclinical Safety, Bayer AG
- Conor O Mahony, Principal Researcher, Tyndall National Institute
- David Hoey, Chief Executive Officer, Vaxxas
- James Birchall, Deputy Head, School of Pharmacy and Pharmaceutical Sciences, College of Biomedical and Life Sciences, Cardiff University
- Lakshmi Jayashankar, Biologist, Influenza & Emerging Infectious Diseases, ASPR/BARDA, U.S. Department of Health and Human Services (HHS)
- Mahmoud Ameri, Vice President, Emergex USA Corporation
- Mateusz Hasso-Agopsowicz, Technical Officer, World Health Organization
- Muhammet Avcil, Managing Director, Imperial BioScience
- Niraj Vasisht, Chief Technology Officer, Corium International
- Nuria Puigmal Dominguez, Founder, LybraBio
- Pawel Biernat, Chief Technology Officer and Co-Founder, Biotts
- Renske Hesselink, CMC Technology Lead, Coalition for Epidemic Preparedness Innovations (CEPI)
- Sanjiv Sharma, Senior Lecturer in Medical Engineering, Swansea University
- Sebastien Henry, EVP of Technical Operations, Micron Biomedical
- Speaker to be confirmed, Crux Product Design Ltd
- Steven Damon, CEO, Micron Biomedical
- Tom Lake, Senior Vice President, Strategic Alliances and Commercialization, Vaxxas
- Waleed Faisal, Project Manager, School of Pharmacy, University College Cork
Please fill in your name and email to receive the Conference Agenda of this event.
Venue
Hilton London Kensington
179-199 Holland Park Ave, Kensington, W11 4UL
London, UK
